The invention further comprises {HEAD ~ a pharmaceutical composition} comprising an antibody of the invention or an antigen binding fragment thereof, a nucleic acid molecule of the invention, or an immunogenic polypeptide of the invention, and a pharmaceutically acceptable diluent or {TAIL ~ carrier} 
comprising
The invention further comprises { HEAD ~ a pharmaceutical composition } comprising an antibody of the invention or an antigen binding fragment thereof , a nucleic acid molecule of the invention , or an immunogenic polypeptide of the invention , and a pharmaceutically acceptable diluent or { TAIL ~ carrier }
OTH OTH OTH OTH HEAD HEAD HEAD HEAD HEAD HEAD HEAD REL OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH TAIL TAIL TAIL TAIL TAIL